title: Management of multidrug-resistant viruses in the immunocompromised host.
abstract: Multidrug-resistant viruses remain a clinically challenging complication in the immunocompromised host. This review discusses mechanisms of viral resistance and treatment options in this context with particular emphasis on the immunocompromised haematology patient. We also outline some of the newer agents and treatment strategies being developed to treat multidrug-resistant viruses.
authors.affiliation: Department of Haematology, University College London Cancer Institute, 72 Huntley Street, London WC1E 6DD, UK. k.peggs@cancer.ucl.ac.uk
authors.forename: Rob S
authors.initials: RS
authors.lastname: Sellar
authors.forename: Karl S
authors.initials: KS
authors.lastname: Peggs
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000187:drug effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000276:immunology; D024921:Drug Resistance, Multiple, Viral / Q000187:drug effects* / Q000276:immunology; D006561:Herpes Simplex / Q000188:drug therapy / Q000276:immunology; D006562:Herpes Zoster / Q000188:drug therapy / Q000276:immunology; D006564:Herpesviridae / Q000187:drug effects*; D014645:Herpesvirus 3, Human / Q000187:drug effects; D006801:Humans; D016867:Immunocompromised Host; D018139:Simplexvirus / Q000187:drug effects
chemical_list: D000998:Antiviral Agents